LX-7101 Uses, Dosage, Side Effects and more
LX-7101 is under investigation in clinical trial NCT01528111 (Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension).
| Trade Name | LX-7101 |
| Generic | LX-7101 |
| Type | |
| Formula | C23H29N7O3 |
| Weight | Average: 451.531 Monoisotopic: 451.233187822 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
